NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR DISSEMINATION IN THE UNITED STATES TORONTO, April 10, 2026 (GLOBE NEWSWIRE) — Consolidated Lithium Metals Inc. (TSXV: CLM | FRA: Z36 | OTCQB: JORFF) (“CLM” or the “Company”) is pleased to announce that, further to its press release on March 18, 2026, it has closed the second and final tranche (the “Final Tranche”) of its previously announced non-brokered offering (the “Offering”) of securities of the Company. Together with the first tranche of the Offering, the Company obtained gross proceeds of approximately $8,935,320. In connection with the Final Tranche, the Company obtained aggregate gross proceeds of approximately $1,050,320 by issuing 10,940,830 flow-through shares of the Company (each, a “Critical FT Share”) at a price of $0.096 per Critical FT Share. Each Critical...

LUXEMBOURG, April 10, 2026 (GLOBE NEWSWIRE) — Tenaris S.A. (NYSE and Mexico: TS and EXM Italy: TEN) announced today that has convened its Annual General Meeting of Shareholders to be held on May 12, 2026, at 10:00 (Central European time), and an Extraordinary General Meeting of Shareholders to be held immediately after the adjournment of the Annual General Meeting of Shareholders. The convening notice (which includes the agendas for the meetings and the procedure for attending and/or voting at the meetings) was published in such newspapers and filed with the regulators, as required by applicable law, and is available on the Luxembourg Stock Exchange’s website at www.bourse.lu/regulated-information-oam, the SEC’s website at www.sec.gov, and Tenaris’s website at ir.tenaris.com. The following documents are also available on Tenaris’s...

WOBURN, Mass., April 10, 2026 (GLOBE NEWSWIRE) — Replimune Group, Inc. (NASDAQ: REPL), a clinical stage biotechnology company pioneering the development of novel oncolytic immunotherapies, today announced that the company received a complete response letter (CRL) from the U.S. Food and Drug Administration (FDA) for the Company’s Biologics License Application (BLA) for RP1 in combination with nivolumab for the treatment of advanced melanoma. Replimune disagrees with the FDA about whether the data set, upon which breakthrough therapy designation was awarded, is sufficient to allow this promising medicine to be made available to advanced cancer patients. In the IGNYTE trial, patients with confirmed progression on an anti-PD-1 based regimen who received RP1 plus nivolumab had a 34% response rate with a median duration of 24.8 months...

TORONTO, April 10, 2026 (GLOBE NEWSWIRE) — Lithium Ionic Corp. (TSXV: LTH; OTCQX: LTHCF; FSE: H3N) (“Lithium Ionic” or the “Company”) is is aware of the Ontario Securities Commission’s publication regarding a regulatory matter involving another reporting issuer and individuals who have, or have had, an association with the Company. Lithium Ionic is not a respondent in this matter and no orders have been sought against Lithium Ionic. The allegations contained in the proceeding have not been proven. The Board of Directors has established a Special Committee of independent directors to oversee the Company’s communications and disclosure in respect of this matter. About Lithium Ionic Corp. Lithium Ionic is a Canadian lithium development company focused on responsibly advancing its 100%-owned Bandeira Lithium...

Senior Vice President, Finance & Accounting John M. Gay named Chief Financial Officer DURHAM, N.C., April 10, 2026 (GLOBE NEWSWIRE) — Pelthos Therapeutics Inc. (NYSE American: PTHS), a biopharmaceutical company committed to commercializing innovative therapeutic products for unmet patient needs (“Pelthos”), today announced John M. Gay has been appointed Chief Financial Officer effective April 10, 2026. Mr. Gay succeeds Francis Knuettel II, who served as Pelthos’ Chief Financial Officer since July 2025. “John played a key role in helping us establish and launch Pelthos. He is an experienced financial leader, and we are excited to have him step into this new role as we continue our strong commercial momentum and enter the next phase of the company’s growth,” said Scott Plesha, CEO of Pelthos. “We also want to thank Frank...

MEXICO CITY, April 10, 2026 (GLOBE NEWSWIRE) — Grupo Aeroméxico S.A.B. de C.V. (NYSE: AERO & BMV: AERO) (“Aeroméxico”) will hold a live conference call and webcast on Wednesday, April 22, 2026, at 10:30 a.m. Mexico City Time (12:30 p.m. Eastern Time) to discuss its first quarter 2026 financial results. During the call, management will review the company’s operating and financial performance for the period, highlighting key business drivers, recent developments, and strategic initiatives that shaped Aeroméxico’s results throughout the first quarter. The event will also include a Q&A session for investors and analysts. A live webcast of this event will be available at https://ir.aeromexico.com/ and an online replay will be available shortly after the webcast is complete. The company’s first quarter 2026 earnings results...

CALGARY, Alberta, April 10, 2026 (GLOBE NEWSWIRE) — TC Energy Corporation (TSX, NYSE: TRP) (TC Energy or the Company) will hold a teleconference and webcast on Friday, May 1, 2026 to discuss its first quarter financial results, and hold its 2026 annual meeting of common shareholders on Thursday, May 7, 2026. First quarter 2026 financial resultsFrançois Poirier, TC Energy President and Chief Executive Officer, Sean O’Donnell, Executive Vice-President and Chief Financial Officer, and other members of the executive leadership team will discuss the financial results and Company developments on Friday, May 1 at 6:30 a.m. MT / 8:30 a.m. ET. Members of the investment community and other interested parties are invited to participate by calling 1-833-752-3826 (Canada/U.S. toll free) or 1-647-846-8864 (International toll). No passcode is...

TORONTO, April 10, 2026 (GLOBE NEWSWIRE) — Kinross Gold Corporation (TSX: K; NYSE: KGC) (the “Company”) received notification that TRC Capital Investment Corporation (“TRC”) has made an unsolicited “mini-tender” offer on April 7, 2026, to purchase up to 2.5 million common shares of Kinross, or approximately 0.21% of Kinross’ shares outstanding, at a price of C$41.75 per share. Kinross strongly recommends that its shareholders reject this offer and cautions its shareholders that the offer made is approximately 4.4% below the closing price of C$43.68 per Kinross share on the Toronto Stock Exchange on April 6, 2026, the day before the offer. Kinross does not endorse TRC’s unsolicited mini-tender offer, and is not affiliated or associated in any way with TRC Capital Investment. TRC has made several similar unsolicited mini-tender offers...

MILWAUKEE, April 10, 2026 (GLOBE NEWSWIRE) — Artisan Partners Asset Management Inc. (NYSE: APAM) today reported that its preliminary assets under management (“AUM”) as of March 31, 2026 totaled $173.0 billion. Artisan Funds and Artisan Global Funds accounted for $84.5 billion of total firm AUM, while separate accounts and other AUM1 accounted for $88.5 billion.PRELIMINARY ASSETS UNDER MANAGEMENT BY STRATEGY2         As of March 31, 2026 – ($ Millions)    Growth Team    Global Opportunities $14,340  Global Discovery 1,026  U.S. Mid-Cap Growth 9,364  U.S. Small-Cap Growth 2,642  Franchise 911  Global Equity Team    Global Equity 393  Non-U.S. Growth 15,456  U.S. Value Team    Value Equity 5,600  U.S. Mid-Cap Value 1,898  Value Income 8  International Value Group    International...